Journal info
|
||
Select Journal
Journals
Bratislava Medical Journal Endocrine Regulations General Physiology and Biophysics Neoplasma 2024 Ahead of print 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 Acta Virologica Studia Psychologica Cardiology Letters Psychológia a patopsych. dieťaťa Kovove Materialy-Metallic Materials Slovenská hudbaWebshop Cart
Your Cart is currently empty.
Info: Your browser does not accept cookies. To put products into your cart and purchase them you need to enable cookies.
2022
Mast cells as a tumor microenvironment factor associated with the aggressiveness of prostate cancer |
Authors: Taras ZADVORNYI, Natalia LUKIANOVA, Tetiana BORIKUN, Andrii TYMOSHENKO, Oleksandr MUSHII, Olena VORONINA, Iurii VITRUK, Eduard STAKHOVSKYI, Vasyl CHEKHUN |
Neoplasma Vol.69, No.6, p. 1490–1498, 2022 |
doi:10.4149/neo_2022_221014N1020 |
Price: free access |
[View Abstract] |
Clinical characteristics and prognostic value of EGFR mutation in stage I lung adenocarcinoma with spread through air spaces after surgical resection |
Authors: Mao-Gang GAO, Shi-Ze WANG, Kai-Hong HAN, Shao-Nan XIE, Qing-Yi LIU |
Neoplasma Vol.69, No.6, p. 1480–1489, 2022 |
doi:10.4149/neo_2022_220619N649 |
Price: free access |
[View Abstract] |
Real-world evidence of efficacy and safety of pomalidomide and dexamethasone in relapsed/refractory multiple myeloma patients: Czech registry data |
Authors: Viera SANDECKA, Luděk POUR, Ivan ŠPIČKA, Jiří MINAŘÍK, Jakub RADOCHA, Tomáš JELÍNEK, Petr PAVLÍČEK, Alexandra JUNGOVÁ, Petr KESSLER, Marek WRÓBEL, Martin ŠTORK, Jan ŠTRAUB, Tomáš PIKA, Lenka ČÁPKOVÁ, Sabina ŠEVČÍKOVÁ, Vladimír MAISNAR, Roman HÁJEK |
Neoplasma Vol.69, No.6, p. 1474–1479, 2022 |
doi:10.4149/neo_2022_220813N827 |
Price: free access |
[View Abstract] |
Burkitt lymphoma-a retrospective analysis of data from the Registry of the Czech Lymphoma Study Group with external validation of the Burkitt lymphoma International Prognostic Index |
Authors: Alice SÝKOROVÁ, Vít PROCHÁZKA, Heidi MÓCIKOVÁ, Andrea JANÍKOVÁ, Robert PYTLÍK, David BELADA, Kateřina BENEŠOVÁ, Pavel KLENER Jr., Juraj ĎURAŠ, Lukáš SMOLEJ, Vít CAMPR, Petra BLAHOVCOVÁ, Marek TRNĚNÝ |
Neoplasma Vol.69, No.6, p. 1466–1473, 2022 |
doi:10.4149/neo_2022_221030N1064 |
Price: free access |
[View Abstract] |
Correlation between gastritis cystica profunda and the risk of lymph node metastasis in early gastric cancer |
Authors: Jia-Jia WU, Yu-Qing CHENG, Hao-Jun YANG, Min LIN |
Neoplasma Vol.69, No.6, p. 1459–1465, 2022 |
doi:10.4149/neo_2022_220314N281 |
Price: free access |
[View Abstract] |
Evaluation of serum glucose-regulated protein 78 (GRP78) as a biomarker of treatment response to bortezomib-based induction regimen in multiple myeloma: A cross-sectional pilot study |
Authors: Suganthi Sekaran RAMACHANDRAN, Pooja GUPTA, Lalit KUMAR, Ritu GUPTA, Lavisha GOEL, Vijay Lakshmi KUMAR, Yogendra Kumar GUPTA |
Neoplasma Vol.69, No.6, p. 1451–1458, 2022 |
doi:10.4149/neo_2022_220526N564 |
Price: free access |
[View Abstract] |
Safety and efficacy of the FLOT regimen in the Polish population - an analysis of the prospective trial |
Authors: Katarzyna Marcisz-Grzanka, Mariola Winiarek, Jakub Pałucki, Paulina Wieszczy, Tomasz Olesiński, Mariusz Jóźwiak, Radosław Samsel, Urszula Sułkowska, Agnieszka Kolasińska-Ćwikła, Lucjan Stanisław Wyrwicz |
Neoplasma Vol.69, No.6, p. 1445–1450, 2022 |
doi:10.4149/neo_2022_220720N734 |
Price: free access |
[View Abstract] |
The prognostic impact of immune checkpoint inhibitors for the treatment of pulmonary sarcomatoid carcinoma: A multicenter retrospective study |
Authors: Jing-Wen Wei, Yue Hao, Jing Xiang, Xing-Xiang Pu, Li-Ping Wang, Zhan-Sheng Jiang, Jing-Xun Wu, Qian Wang, Chun-Wei Xu, Wen-Xian Wang, Zheng-Bo Song |
Neoplasma Vol.69, No.6, p. 1437–1444, 2022 |
doi:10.4149/neo_2022_220617N644 |
Price: free access |
[View Abstract] |
Moderately hypofractionated salvage radiotherapy in patients with biochemical recurrence of prostate cancer after prostatectomy: long-term results and comparative analysis of two schedules |
Authors: Fabio Matrone, Alessandra Donofrio, Giuseppe Fanetti, Alberto Revelant, Jerry Polesel, Paola Chiovati, Roberto Bortolus |
Neoplasma Vol.69, No.6, p. 1425–1436, 2022 |
doi:10.4149/neo_2022_220825N864 |
Price: free access |
[View Abstract] |
TLR2 and TLR4 in colorectal cancer: relationship to tumor necrosis and markers of systemic inflammation |
Authors: Karoliina Paarnio, Juha P Väyrynen, Sara A Väyrynen, Tiina Kantola, Timo Karhu, Taina Tervahartiala, Kai Klintrup, Timo Sorsa, Tuula Salo, Jyrki Mäkelä, Tuomo J Karttunen |
Neoplasma Vol.69, No.6, p. 1418–1424, 2022 |
doi:10.4149/neo_2022_220509N498 |
Price: free access |
[View Abstract] |
LncRNA CBR3-AS1 predicts a poor prognosis and promotes cervical cancer progression through the miR-3163/LASP1 pathway |
Authors: Yi-Pin CAI, Yu HUANG, Jie ZHANG, Xiao-Li LIU, Fang ZHAO, Kuan ZHANG, Song-Yuan XU, Yan YANG, Hai-Wei HUANG, Yu GAO |
Neoplasma Vol.69, No.6, p. 1406–1417, 2022 |
doi:10.4149/neo_2022_220730N784 |
Price: free access |
[View Abstract] |
Stanniocalcin1 knockdown induces ferroptosis and suppresses glycolysis in prostate cancer via the Nrf2 pathway |
Authors: Yuan-Qing DAI, Yao BAI, Jie GU, Ben-Yi FAN |
Neoplasma Vol.69, No.6, p. 1396–1405, 2022 |
doi:10.4149/neo_2022_220626N665 |
Price: free access |
[View Abstract] |
GDF11 knockdown downregulates SMURF1 to inhibit breast cancer progression by activation of p53 and inactivation of ERα signaling |
Authors: Hai-Li TANG, Qi WANG, Jian-Guo LU, Xiao-Jun YANG, Jiao-Jiao SHI, Sheng-Peng WANG, Chang-Qing CAO, Hua-Dong ZHAO |
Neoplasma Vol.69, No.6, p. 1386–1395, 2022 |
doi:10.4149/neo_2022_220607N601 |
Price: free access |
[View Abstract] |
SUMO1-modified DNA methyltransferase 1 induces DNA hypermethylation of VWC2 in the development of colorectal cancer |
Authors: Xiao-Hu Cheng, Tong-Tong Xu, Lian-Bang Zhou, Fang-Yuan Li, Song Wang, Huan-Ru Liang, Jing-Jing Tang, Chang-Qin Duan, Heng Jiang, Ying-Feng Zhang, Zhi-Ning Liu |
Neoplasma Vol.69, No.6, p. 1373–1385, 2022 |
doi:10.4149/neo_2022_220817N841 |
Price: free access |
[View Abstract] |
miR-550a-5p promotes the proliferation and migration of hepatocellular carcinoma by targeting GNE via the Wnt/β-catenin signaling pathway |
Authors: Chun-Ming Li, Wu Wu, Zhu Zhu, Pei-Lin Lu, Jian-Ping Gong, Rong Ma |
Neoplasma Vol.69, No.6, p. 1359–1372, 2022 |
doi:10.4149/neo_2022_220727N774 |
Price: free access |
[View Abstract] |
PHF21A expression as a biomarker of hepatocellular carcinoma progression and prognosis |
Authors: Jia-Qing Huang, Li-Chen Ji, Qian-Gan Jing, Yi-Chen He, Ying-Yu Ma, Xiang-Min Tong |
Neoplasma Vol.69, No.6, p. 1349–1358, 2022 |
doi:10.4149/neo_2022_220807N806 |
Price: free access |
[View Abstract] |
PRKAA1, stabilized by FTO in an m6A-YTHDF2-dependent manner, promotes cell proliferation and glycolysis of gastric cancer by regulating the redox balance |
Authors: Yangmei Zhang, Xichang Zhou, Xue Cheng, Xiou Hong, Xiaowei Jiang, Guilong Jing, Kai Chen, Yang Li |
Neoplasma Vol.69, No.6, p. 1338–1348, 2022 |
doi:10.4149/neo_2022_220714N714 |
Price: free access |
[View Abstract] |
Functions of long non-coding RNA LNC11649 in non-small cell lung cancer cells as a reprocessed form of MALAT1 |
Authors: Jun-Zhe Qi, Ting-Ting Zhao, Shu-Shan Qi |
Neoplasma Vol.69, No.6, p. 1322–1337, 2022 |
doi:10.4149/neo_2022_220705N689 |
Price: free access |
[View Abstract] |
Mutational landscape of DNA damage response deficiency-related genes and its association with immune biomarkers in esophageal squamous cell carcinoma |
Authors: Gang Chen, Yong-Jun Zhu, Ji Chen, Feng Miao, Ning Wu, Yang Song, Bei-Bei Mao, Sheng-Zhou Wang, Fei Xu, Zhi-Ming Chen |
Neoplasma Vol.69, No.6, p. 1314–1321, 2022 |
doi:10.4149/neo_2022_220721N738 |
Price: free access |
[View Abstract] |
HOXC10 indicates poor survival outcome in gastric cancer and promotes G1/S cell cycle transition through transcriptional repression of p21 |
Authors: Zheng-Hua Lin, Jia-Min He, San-Chuan Lai, Ning Ding, Ying Jiang, Xing-Kang He, Xiao-Sun Liu, Zhi-Hui Huang |
Neoplasma Vol.69, No.6, p. 1303–1313, 2022 |
doi:10.4149/neo_2022_220609N615 |
Price: free access |
[View Abstract] |